All for one, not one for all: The promise and challenges of personalized medicine
By Lori L. Burrows, Professor of Biocchemistry and Biomedical Sciences, McMaster University
Elizabeth C. Li, Master's student in the Biomedical Discovery and Commercialization program, McMaster University
Personalized medicine is a promising treatment for recurrent cancer and superbugs, but it is labour-intensive and expensive, and pathways for its regulatory approval and reimbursement are complicated.
Read complete article
© The Conversation
-
Tuesday, August 13, 2024